Zevra Therapeutics (ZVRA) Capital Expenditures (2014 - 2026)
Zevra Therapeutics (ZVRA) reported Capital Expenditures of $217,000 for Q2 2026, up 1.9% from $213,000 a year earlier and up 520.0% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Capital Expenditures (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Zevra Therapeutics' Capital Expenditures came in at $775,000, up 148.4% year-over-year; for FY2025, it was $835,000.
- Capital Expenditures has a five-year compound annual growth rate of 90.8% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $296,000 in FY2023 (+218.3%), $93,000 in FY2022 (-8.8%) and $102,000 in FY2021 (+209.1%).
- Five-year quarterly Capital Expenditures spans a low of -$31,000 in Q4 2025 and a high of $554,000 in Q3 2025.
- The high point for year-over-year Capital Expenditures in five years was Q3 2022 (growth of 600.0%); the low point was Q2 2022 (a decline of 81.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $35,000 (Q1 2026), -$31,000 (Q4 2025) and $554,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -321.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -763.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Zevra Therapeutics | 592.83 Mn | -219.88 Mn | 38.18 Mn | 217,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 217,000.00 |
| Mar 31, 2026 | 35,000.00 |
| Dec 31, 2025 | -31,000.00 |
| Sep 30, 2025 | 554,000.00 |
| Jun 30, 2025 | 213,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Dec 31, 2023 | 72,000.00 |
| Sep 30, 2023 | 172,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | 29,000.00 |
| Dec 31, 2022 | 34,000.00 |
| Sep 30, 2022 | 28,000.00 |
| Jun 30, 2022 | 15,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 17,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 81,000.00 |
| Dec 31, 2020 | 26,000.00 |
| Jun 30, 2020 | -4,000.00 |
| Mar 31, 2020 | 11,000.00 |
API Access
Zevra Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();